Nurse Practitioner · Clarkston, MI
NPI
1255789202
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5680 Bow Pointe Dr Ste 202
Clarkston, MI, 48346
Phone (248) 922-6650
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
150 services
Medicare patients, 2024
77
Average age 72
Drug cost, 2024
$5.2M
1,071 prescriptions
Company payments, 2025
$518
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer Kinaia was code 99214 (office e&m - established), 80 times for 43 patients. In total Jennifer Kinaia billed 150 services in 5 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 80 | 43 | $68.92 | $5,514 |
| 99213 Office E&M - Established | Office | 43 | 26 | $45.12 | $1,940 |
| 99215 Office E&M - Established | Office | 25 | 25 | $101.09 | $2,527 |
By year: 2022 $8,605 for 133 services; 2023 $7,142 for 127 services; 2024 $10K for 150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer Kinaia prescribed most often to Medicare patients was Eliquis (Apixaban), with 85 prescriptions and refills. In total Jennifer Kinaia wrote 1,071 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 85 | 153 | 22 | $87K |
| Ondansetron Hcl Generic | 85 | 89 | 62 | $918 |
| Prochlorperazine Maleate Generic | 76 | 78 | 60 | $3,342 |
| Xarelto Rivaroxaban | 61 | 135 | 18 | $72K |
| Revlimid Lenalidomide | 49 | 49 | Under 11 | $888K |
| Anastrozole Generic | 46 | 79 | 12 | $1,640 |
| Tagrisso Osimertinib Mesylate | 40 | 40 | Under 11 | $688K |
| Imbruvica Ibrutinib | 33 | 39 | Under 11 | $527K |
| Ibrance Palbociclib | 31 | 31 | Under 11 | $517K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 30 | 30 | 21 | $246 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 30 | 30 | Under 11 | $785 |
| Mirtazapine Generic | 26 | 30 | Under 11 | $304 |
| Fondaparinux Sodium Generic | 24 | 24 | Under 11 | $44K |
| Pantoprazole Sodium Generic | 23 | 44 | Under 11 | $351 |
| Acyclovir Generic | 20 | 24 | Under 11 | $148 |
Brand drugs: - claims; generic drugs: 628 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer Kinaia $518 ($518 in general payments such as food, travel and fees) from 14 companies. The largest payer was Incyte Corporation with $99.95.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 1 | $99.95 |
| Abbvie Inc. ABBV | 2 | $65.45 |
| Sobi, Inc SOBI.ST | 2 | $52.48 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $41.28 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $38.19 |
| Servier Pharmaceuticals LLC | 2 | $34.74 |
| Merck Sharp & Dohme LLC MRK | 1 | $32.68 |
| Genzyme Corporation SNY | 1 | $29.42 |
| GlaxoSmithKline, LLC. GSK | 1 | $24.39 |
| Celgene Corporation BMY | 1 | $20.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.